References
- Bordigoni P, Benz-Lemoine E, Fisher A. Bone marrow transplantation following busulfan, cyclophosphamide and high-dose cytosine arabinoside as treatment for infants with translocation (4; 11) leukaemia. Br J Haematol. 1989; 72: 293–294
- Bordigoni P, Vernant J P, Souillet G. Allogeneic bone marrow transplantation in first marrow remission for children with high risk acute lymphoblastic leukaemia. J Clin Oncol. 1989; 7: 747–753
- Chastagner P, Bene M C, Sommelet D, Gobert B, Schmitt C, Faure G. Association of anticardiolipin antibodies (ACA) and auto-immune thrombocytopenic purpura in children. Int JP ediatr Hematol Oncol. 1996; 3: 267–271
- Chastagner P, Kalifa C, Mechinaud-Lacroix F. Phase II study of combined BCNU, cisplatinum and VP16 for the treatment of high grade glioma in children. Med Pediatr Oncol. 1995; 25: 258
- Raney B, Parham D, Sommelet-Olive D, Stevens M C, Treuner J, Carli M. Summary of the International Symposium on Childhood Non-Rhabdomyosarcoma Soft-Tissue Sarcomas, Padua, Italy, 10–12 February 1994. Med Pediatr Oncol. 1996; 26: 425–430
- Malvy D J, Arnaud J, Burtschy B. Antioxidant micronutrients and childhood malignancy during Oncological treatment. Med Pediatr Oncol. 1997; 29: 213–217
- Schaison G, Sommelet D. Pediatric hematology and Oncology in France. Pediatr Hematol Oncol. 1995; 12: 377–385